Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume
Sep 1, 2026
Sale
Shares
97,581
Price
$38.42
Total Value
$3.75M
Shares Held After
100,373
% of Holdings
49.3%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Sep 1, 2026
Sale
Shares
9,000
Price
$46.99
Total Value
$422.87K
Shares Held After
65,389
% of Holdings
12.1%
Sep 1, 2026
Sale
Shares
4,800
Price
$92.44
Total Value
$443.69K
Shares Held After
925,580
% of Holdings
0.5%
Sep 1, 2026
Sale
Shares
63,596
Price
$91.90
Total Value
$5.84M
Shares Held After
930,380
% of Holdings
6.4%
Sep 1, 2026
Sale
Shares
6,604
Price
$90.79
Total Value
$599.56K
Shares Held After
993,976
% of Holdings
0.7%
Sep 1, 2026
Sale
Shares
10,131
Price
$23.10
Total Value
$234.03K
Shares Held After
6,526,633
% of Holdings
0.2%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Sep 1, 2026
Sale
Shares
4,000
Price
$92.01
Total Value
$368.05K
Shares Held After
236,384
% of Holdings
1.7%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Sep 1, 2026
Sale
Shares
1,000
Price
$91.05
Total Value
$91.05K
Shares Held After
240,384
% of Holdings
0.4%
Sep 1, 2026
Sale
Shares
10,131
Price
$23.10
Total Value
$234.03K
Shares Held After
6,526,633
% of Holdings
0.2%

Xeris Biopharma Holdings, Inc. (XERS)

McCulloch Kevin — President and Chief Operating Officer
Sep 1, 2026
Sale
Shares
15,000
Price
$8.49
Total Value
$127.31K
Shares Held After
1,639,208
% of Holdings
0.9%

Xeris Biopharma Holdings, Inc. (XERS)

Hecht Beth — Chief Legal Officer and Corporate Secretary
Sep 1, 2026
Sale
Shares
16,666
Price
$8.49
Total Value
$141.43K
Shares Held After
1,127,796
% of Holdings
1.5%

Xeris Biopharma Holdings, Inc. (XERS)

Pieper Steven — Chief Financial Officer
Sep 1, 2026
Sale
Shares
5,000
Price
$8.50
Total Value
$42.50K
Shares Held After
1,356,053
% of Holdings
0.4%

Nurix Therapeutics, Inc. (NRIX)

Hansen Gwenn — Chief Scientific Officer
Sep 1, 2026
Sale
Shares
1,452
Price
$25.47
Total Value
$36.98K
Shares Held After
117,227
% of Holdings
1.2%
Sep 1, 2026
Sale
Shares
15,000
Price
$5.86
Total Value
$87.97K
Shares Held After
62,065
% of Holdings
19.5%
Sep 1, 2026
Sale
Shares
10,131
Price
$23.10
Total Value
$234.03K
Shares Held After
6,526,633
% of Holdings
0.2%

ICU MEDICAL INC/DE (ICUI)

Bonnell Brian Michael — Chief Financial Officer
Sep 1, 2026
Sale
Shares
6,381
Price
$175.00
Total Value
$1.12M
Shares Held After
56,062
% of Holdings
10.2%
Sep 1, 2026
Sale
Shares
5,000
Price
$71.48
Total Value
$357.40K
Shares Held After
10,784
% of Holdings
31.7%

FENNEC PHARMACEUTICALS INC. (FENC)

Raykov Rosty — Former Director
Sep 1, 2026
Sale
Shares
10,000
Price
$12.11
Total Value
$121.10K
Shares Held After
124,411
% of Holdings
7.4%
Aug 31, 2026
Sale
Shares
2,850
Price
$72.80
Total Value
$207.48K
Shares Held After
171,843
% of Holdings
1.6%

NovaBridge Biosciences (NBP)

Xu Cong Claire — EVP, Clinical Development
Aug 31, 2026
Sale
Shares
3,282
Price
$0.79
Total Value
$2.59K
Shares Held After
304,201
% of Holdings
1.1%
Aug 31, 2026
Sale
Shares
1,276
Price
$4.66
Total Value
$5.95K
Shares Held After
454
% of Holdings
73.8%

Imunon, Inc. (IMNN)

Eylward Susan — General Counsel and Corp Sec
Aug 31, 2026
Sale
Shares
2,525
Price
$1.56
Total Value
$3.95K
Shares Held After
2,896
% of Holdings
46.6%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Smith Hunter C — Chief Financial Officer
Aug 31, 2026
Sale
Shares
28,188
Price
$106.20
Total Value
$2.99M
Shares Held After
114,024
% of Holdings
19.8%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Smith Hunter C — Chief Financial Officer
Aug 31, 2026
Sale
Shares
11,514
Price
$105.37
Total Value
$1.21M
Shares Held After
142,212
% of Holdings
7.5%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Smith Hunter C — Chief Financial Officer
Aug 31, 2026
Sale
Shares
23,072
Price
$104.59
Total Value
$2.41M
Shares Held After
153,726
% of Holdings
13.0%
Aug 31, 2026
Sale
Shares
3,733
Price
$614.38
Total Value
$2.29M
Shares Held After
23,216
% of Holdings
13.9%
Aug 31, 2026
Sale
Shares
400
Price
$614.38
Total Value
$245.75K
Shares Held After
23,216
% of Holdings
1.7%

Encompass Health Corp (EHC)

Darby John Patrick — EVP, Gen Counsel&Secretary
Aug 31, 2026
Sale
Shares
4,858
Price
$121.09
Total Value
$588.26K
Shares Held After
75,041
% of Holdings
6.1%

Encompass Health Corp (EHC)

Price Andrew L — Chief Accounting Officer
Aug 31, 2026
Sale
Shares
5,211
Price
$120.93
Total Value
$630.17K
Shares Held After
69,483
% of Holdings
7.0%

FENNEC PHARMACEUTICALS INC. (FENC)

Sayad Pierre Sargis — Chief Medical Officer
Aug 31, 2026
Sale
Shares
12,000
Price
$12.18
Total Value
$146.16K
Shares Held After
9,519
% of Holdings
55.8%
Aug 31, 2026
Purchase
Shares
217
Price
$69.10
Total Value
$14.99K
Shares Held After
525,217
% of Holdings
0.0%
Aug 31, 2026
Purchase
Shares
5,000
Price
$68.23
Total Value
$341.18K
Shares Held After
525,000
% of Holdings
1.0%
Aug 31, 2026
Sale
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
Aug 31, 2026
Sale
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%

Edwards Lifesciences Corp (EW)

Dahl Andrew M. — SVP, Corporate Controller
Aug 31, 2026
Sale
Shares
544
Price
$91.06
Total Value
$49.53K
Shares Held After
14,868
% of Holdings
3.5%

CYTOKINETICS INC (CYTK)

Blum Robert I — Director
Aug 31, 2026
Sale
Shares
7,500
Price
$70.24
Total Value
$526.80K
Shares Held After
377,820
% of Holdings
1.9%

ICU MEDICAL INC/DE (ICUI)

Bonnell Brian Michael — Chief Financial Officer
Aug 31, 2026
Sale
Shares
1,113
Price
$173.91
Total Value
$193.57K
Shares Held After
62,443
% of Holdings
1.8%

ICU MEDICAL INC/DE (ICUI)

Bonnell Brian Michael — Chief Financial Officer
Aug 31, 2026
Sale
Shares
4,568
Price
$173.44
Total Value
$792.29K
Shares Held After
63,556
% of Holdings
6.7%

ICU MEDICAL INC/DE (ICUI)

Bonnell Brian Michael — Chief Financial Officer
Aug 31, 2026
Sale
Shares
1,914
Price
$172.12
Total Value
$329.44K
Shares Held After
68,124
% of Holdings
2.7%

ICU MEDICAL INC/DE (ICUI)

Bonnell Brian Michael — Chief Financial Officer
Aug 31, 2026
Sale
Shares
1,712
Price
$171.05
Total Value
$292.84K
Shares Held After
70,038
% of Holdings
2.4%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Aug 31, 2026
Sale
Shares
10,000
Price
$70.24
Total Value
$702.40K
Shares Held After
58,555
% of Holdings
14.6%
Shares
3,500
Price
$0.05
Total Value
$171.50
Shares Held After
9,384,256
% of Holdings
0.0%
Aug 31, 2026
Purchase
Shares
27,304
Price
$3.54
Total Value
$96.60K
Shares Held After
294,784
% of Holdings
9.3%

Roivant Sciences Ltd. (ROIV)

Venker Eric — President&Immunovant CEO
Aug 28, 2026
Sale
Shares
33,818
Price
$36.44
Total Value
$1.23M
Shares Held After
1,599,154
% of Holdings
2.1%

Roivant Sciences Ltd. (ROIV)

Venker Eric — President&Immunovant CEO
Aug 28, 2026
Sale
Shares
166,182
Price
$35.63
Total Value
$5.92M
Shares Held After
1,632,972
% of Holdings
9.2%
Aug 28, 2026
Sale
Shares
4,615
Price
$39.25
Total Value
$181.14K
Shares Held After
197,954
% of Holdings
2.3%
Aug 28, 2026
Sale
Shares
21,792
Price
$38.16
Total Value
$831.58K
Shares Held After
202,569
% of Holdings
9.7%
Aug 28, 2026
Sale
Shares
326,700
Price
$23.04
Total Value
$7.53M
Shares Held After
6,536,764
% of Holdings
4.8%
Aug 28, 2026
Sale
Shares
326,700
Price
$23.04
Total Value
$7.53M
Shares Held After
6,536,764
% of Holdings
4.8%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Aug 28, 2026
Sale
Shares
10
Price
$182.50
Total Value
$1.82K
Shares Held After
73,890
% of Holdings
0.0%
Version: v26.7.3